Esaxerenone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEsaxerenone
Drug Alias Name艾沙利酮esaxerenonaesaxerenonum依沙利酮Minnebro +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMineralocorticoid receptor antagonists
TargetsMineralocorticoid receptor
Therapy Area/IndicationsEssential HypertensionHypertensionDiabetic Nephropathies
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/01/08
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesDaiichi Sankyo Inc
Active IndicationsHypertension
Inactive IndicationsEssential HypertensionDiabetic Nephropathies

Other Information

ATC CodeC02